An Open Label, Multicenter Phase II Study to Evaluate Efficacy and Safety of P276-00 in Indian Subjects With Recurrent, Metastatic or Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs P 276 (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- Acronyms MONARCH
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jan 2013 Planned end date changed from 1 Feb 2012 to 1 Apr 2011 as reported by ClinicalTrials.gov.
- 19 Jan 2012 Planned end date changed from 1 Jul 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.